Magellan Financial Group Ltd (MFG)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 8.550 |
|---|---|
| 52-week range | 7.407 – 11.222 |
| Return, 1 month / 3 months | +1.2% / −10.1% |
| Return, 1 year / 3 years | −11.2% / +65.0% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 48.1% |
| Worst drawdown (1 year) | -28.1% |
| Average daily value traded | 9.78M AUD |
| Dividend yield | 7.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Magellan Financial Group is an Australian investment management company based in Sydney. It manages funds for retail and institutional investors, focusing on global equities and global infrastructure, and also provides related financial services. Its clients include individual investors and financial advisers who access the funds through investment platforms, along with institutional investors such as superannuation funds. The company earns fees for managing these portfolios and for associated services.
Magellan Financial Group Ltd trades under the code MFG on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Magellan Financial Group Ltd (MFG) trades on the Australian Securities Exchange in Australia. It last closed at AUD 8.550 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 415 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.2% and over the last three months it fell 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.6% | ||
| From 52-week high | -23.8% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -10.1% | ||
| 6-month return | -10.6% | ||
| 12-month return, skipping the last month | -12.3% | ||
| Risk (lower is better) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 48.1% | ||
| Worst drawdown (1 year) | -28.1% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 9.78M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.6% | ||
| Years with dividends | 5 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +1.2% |
| 3 months | −10.1% |
| 6 months | −10.6% |
| 1 year | −11.2% |
| 3 years | +65.0% |
| 5 years | −63.7% |
Signals
| 50-day / 200-day average | 8.947 / 9.056 |
|---|---|
| Golden / death cross (60 days) | Death, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.221 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2026 | AUD 0.2550 |
| 23 Feb 2026 | AUD 0.3950 |
| 25 Aug 2025 | AUD 0.4690 |
| 25 Feb 2025 | AUD 0.2640 |
| 20 Aug 2024 | AUD 0.3570 |
| 20 Feb 2024 | AUD 0.2940 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.